Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (5): 1-7.doi: 10.6040/j.issn.1671-7554.0.2021.0319
• Current Advance of Basic and Clinical Medical Virology • Next Articles
CLC Number:
1 |
Hswen Y , Brownstein JS , Liu J , et al. Use of a digital health application for in fluenza surveillance in china[J]. Am J Public Health, 2017, 107 (7): 1130- 1136.
doi: 10.2105/AJPH.2017.303767 |
2 | CDC. Seasonal influenza vaccine effectiveness, 2004-2018 [EB/OL]. (2020-12-11)[2021-03-01]. https: //www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm. |
3 |
Wen S , Wu Z , Zhong S , et al. Factors influencing the immunogenicity of influenza vaccines[J]. Hum Vaccin Immunother, 2021, 1- 13.
doi: 10.1080/21645515.2021.1875761 |
4 | Simonsen L , Viboud C , Taylor RJ . Effectiveness of influenza vaccination[J]. N Engl J Med, 2007, 357 (26): 2729- 2730. |
5 |
Herrera GA , Iwane MK , Cortese M , et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004[J]. Vaccine, 2007, 25 (1): 154- 160.
doi: 10.1016/j.vaccine.2006.05.129 |
6 |
Morimoto N , Takeishi K . Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: a systematic review and meta-analysis[J]. Vaccine, 2018, 36 (7): 949- 957.
doi: 10.1016/j.vaccine.2018.01.023 |
7 |
Darvishian M , Dijkstra F , van Doorn E , et al. Influenza vaccine effectiveness in the netherlands from 2003/2004 through 2013/2014: the importance of circulating influenza virus types and subtypes[J]. PLoS One, 2017, 12 (1): e0169528.
doi: 10.1371/joural.pone.0169525 |
8 |
Loubet P , Loulergue P , Galtier F , et al. Seasonal influenza vaccination of high-risk adults[J]. Expert Rev Vaccines, 2016, 15 (12): 1507- 1518.
doi: 10.1080/14760584.2016.1188696 |
9 |
Sano K , Ainai A , Suzuki T , et al. The road to a more effective influenza vaccine: Up to date studies and future prospects[J]. Vaccine, 2017, 35 (40): 5388- 5395.
doi: 10.1016/j.vaccine.2017.08.034 |
10 |
Heikkinen T , Heinonen S . Effectiveness and safety of influenza vaccination in children: European perspective[J]. Vaccine, 2011, 29 (43): 7529- 7534.
doi: 10.1016/j.vaccine.2011.08.011 |
11 |
Ambrose CS , Levin MJ , Belshe RB . The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults[J]. Influenza Other Respir Viruses, 2011, 5 (2): 67- 75.
doi: 10.1111/j.1750-2659.2010.00183.x |
12 |
Cox MM , Hollister JR . FluBlok, a next generation influenza vaccine manufactured in insect cells[J]. Biologicals, 2009, 37 (3): 182- 189.
doi: 10.1016/j.biologicals.2009.02.014 |
13 |
Jackson LA , Chen WH , Stapleton JT , et al. Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons[J]. J Infect Dis, 2012, 206 (6): 811- 820.
doi: 10.1093/infdis/jis427 |
14 |
Vesikari T , Forsten A , Arora A , et al. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine[J]. Hum Vaccin Immunother, 2015, 11 (8): 2102- 2112.
doi: 10.1080/21645515.2015.1044167 |
15 |
Clark TW , Pareek M , Hoschler K , et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine[J]. N Engl J Med, 2009, 361 (25): 2424- 2435.
doi: 10.1056/NEJMoa0907650 |
16 | CDC. Adjuvanted flu vaccine[EB/OL]. (2021-01-25) [2021-03-01]. https: //www.cdc.gov/flu/prevent/adjuvant.htm. |
17 |
Engler RJ , Nelson MR , Klote MM , et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses[J]. Arch Intern Med, 2008, 168 (22): 2405- 2414.
doi: 10.1001/archinternmed.2008.513 |
18 |
Amadori A , Zamarchi R , De Silvestro G , et al. Genetic control of the CD4/CD8 T-cell ratio in humans[J]. Nat Med, 1995, 1 (12): 1279- 1283.
doi: 10.1038/nm1295-1279 |
19 |
Huygen K , Palfliet K . Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD Ⅱ. Importance of one major autosomal locus and additional sexual influences[J]. Cell Immunol, 1984, 85 (1): 75- 81.
doi: 10.1016/0008-8749(84)90279-X |
20 |
Furman D , Hejblum BP , Simon N , et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination[J]. Proc Natl Acad Sci U S A, 2014, 111 (2): 869- 874.
doi: 10.1073/pnas.1321060111 |
21 |
Hewagama A , Patel D , Yarlagadda S , et al. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis[J]. Genes Immun, 2009, 10 (5): 509- 516.
doi: 10.1038/gene.2009.12 |
22 |
Lu FX , Abel K , Ma Z , et al. The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones[J]. Clin Exp Immunol, 2002, 128 (1): 10- 20.
doi: 10.1046/j.1365-2249.2002.01780.x |
23 |
Egawa Y , Ohfuji S , Fukushima W , et al. Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus: with special reference to age, body mass index, and HbA1c[J]. Hum Vaccin Immunother, 2014, 10 (5): 1187- 1194.
doi: 10.4161/hv.28252 |
24 |
Zimmermann P , Curtis N . The influence of the intestinal microbiome on vaccine responses[J]. Vaccine, 2018, 36 (30): 4433- 4439.
doi: 10.1016/j.vaccine.2018.04.066 |
25 |
Mukherjee S , Huda S , Sinha Babu SP . Toll-like receptor polymorphism in host immune response to infectious diseases: A review[J]. Scand J Immunol, 2019, 90 (1): e12771.
doi: 10.1111/sji.12771 |
26 |
Didierlaurent A , Ferrero I , Otten LA , et al. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response[J]. J Immunol, 2004, 172 (11): 6922- 6930.
doi: 10.4049/jimmunol.172.11.6922 |
27 |
Yang J , Yan H . TLR5: beyond the recognition of flagellin[J]. Cell Mol Immunol, 2017, 14 (12): 1017- 1019.
doi: 10.1038/cmi.2017.122 |
28 |
Oh JZ , Ravindran R , Chassaing B , et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination[J]. Immunity, 2014, 41 (3): 478- 492.
doi: 10.1016/j.immuni.2014.08.009 |
29 |
Hong SH , Byun YH , Nguyen CT , et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection[J]. Vaccine, 2012, 30 (2): 466- 474.
doi: 10.1016/j.vaccine.2011.10.058 |
30 |
Kim JR , Holbrook BC , Hayward SL , et al. Inclusion of flagellin during vaccination against influenza enhances recall responses in nonhuman primate neonates[J]. J Virol, 2015, 89 (14): 7291- 7303.
doi: 10.1128/JVI.00549-15 |
31 |
Cui B , Liu X , Fang Y , et al. Flagellin as a vaccine adjuvant[J]. Expert Rev Vaccines, 2018, 17 (4): 335- 349.
doi: 10.1080/14760584.2018.1457443 |
32 |
Ciabattini A , Olivieri R , Lazzeri E , et al. Role of the microbiota in the modulation of vaccine immune responses[J]. Front Microbiol, 2019, 10, 1305.
doi: 10.3389/fmicb.2019.01305 |
33 |
Andrews SF , Kaur K , Pauli NT , et al. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response[J]. J Virol, 2015, 89 (6): 3308- 3317.
doi: 10.1128/JVI.02871-14 |
34 |
Sasaki S , He XS , Holmes TH , et al. Influence of prior influenza vaccination on antibody and B-cell responses[J]. PLoS One, 2008, 3 (8): e2975.
doi: 10.1371/joural.pone.0002975 |
35 |
Khurana S , Hahn M , Coyle EM , et al. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans[J]. Nat Commun, 2019, 10 (1): 3338.
doi: 10.1038/s41467-019-11296-5 |
36 | 钟舒怡, 文思敏, 李茂, 等. 免疫相关基因多态性与流感疫苗应答的关联[J]. 中国疫苗和免疫, 2019, 25 (6): 736- 742. |
ZHONG Shuyi , WEN Simin , LI Mao , et al. Relationship between immune related single nucleotide polymorphisms and the immune response to influenza vaccine[J]. Chinese Vaccines and Immunization, 2019, 25 (6): 736- 742. | |
37 |
Spencer MJ , Cherry JD , Terasaki PI . HL-A antigens and antibody response after influenza a vaccination[J]. N Engl J Med, 1976, 294 (1): 13- 16.
doi: 10.1056/NEJM197601012940104 |
38 |
Moss AJ , Gaughran FP , Karasu A , et al. Correlation between human leukocyte antigen class Ⅱ alleles and HAI titers detected post-influenza vaccination[J]. PLoS One, 2013, 8 (8): e71376.
doi: 10.1371/joural.pone.0071376 |
39 |
Gelder CM , Lambkin R , Hart KW , et al. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine[J]. J Infect Dis, 2002, 185 (1): 114- 117.
doi: 10.1086/338014 |
40 | Poland GA , Ovsyannikova IG , Jacobson RM . Immunogenetics of seasonal influenza vaccine response[J]. Vaccine, 2008, 26 (Suppl4): 35- 40. |
41 |
Narwaney KJ , Glanz JM , Norris JM , et al. Association of HLA class Ⅱ genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children[J]. Vaccine, 2013, 31 (7): 1123- 1128.
doi: 10.1016/j.vaccine.2012.12.026 |
42 |
Egli A , Santer DM , OShea D , et al. IL-28B is a key regulator of B-and T-cell vaccine responses against influenza[J]. PLoS Pathog, 2014, 10 (12): e1004556.
doi: 10.1371/journal.ppat.1004556 |
43 |
Lei N , Li Y , Sun Q , et al. IFITM3 affects the level of antibody response after influenza vaccination[J]. Emerg Microbes Infect, 2020, 9 (1): 976- 987.
doi: 10.1080/22221751.2020.1756696 |
44 |
Qin L , Wang D , Li D , et al. High level antibody response to pandemic influenza H1N1/09 virus is associated with interferon-induced transmembrane protein-3 rs12252-CC in young adults[J]. Front Cell Infect Microbiol, 2018, 8, 134.
doi: 10.3389/fcimb.2018.00134 |
45 |
Cummins NW , Weaver EA , May SM , et al. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice[J]. FASEB J, 2012, 26 (7): 2911- 2918.
doi: 10.1096/fj.11-190017 |
46 |
国家免疫规划技术工作组流感疫苗工作组. 中国流感疫苗预防接种技术指南(2020-2021)[J]. 中华流行病学杂志, 2020, 41 (10): 1555- 1576.
doi: 10.3760/cma.j.cn112338-20200904-01126 |
Influenza Vaccine Working Group of Technical Working Group on National Immunization Programme . Technical guidelines for influenza vaccination in China (2020-2021)[J]. Chinese Journal of Epidemiology, 2020, 41 (10): 1555- 1576.
doi: 10.3760/cma.j.cn112338-20200904-01126 |
|
47 |
Wang R , Song A , Levin J , et al. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein[J]. Antiviral Res, 2008, 80 (2): 168- 177.
doi: 10.1016/j.antiviral.2008.06.002 |
48 | 刘雪洁, 赵天旖, 袁丽芳, 等. 通用型流感疫苗的研究现状与展望[J]. 病毒学报, 2021, 37 (2): 471- 482. |
LIU Xuejie , ZHAO Tianyi , YUAN Lifang , et al. Research status and prospect of universal influenza vaccine[J]. Chinese Journal of Virology, 2021, 37 (2): 471- 482. |
[1] | ZHAO Xiuqin, DENG Chunying, LI Shiying, ZHANG Jinxia, HE Yonggui, YU Hong, LIU Bin. Neuroprotective effect of dl-3n-butylphthalide on focal cerebral ischemia reperfusion injury in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 25-31. |
[2] | LI Xin, WANG Gongming, WANG Hong, WANG Yan, ZHANG Ligong, ZHANG Le, LIU Bei, ZHANG Mengyuan. Inducible nitric oxide synthase contributes to the delayed cardioprotection of ischemic postconditioning in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 16-20. |
|